Differential research impact in cancer practice guidelines' evidence base: lessons from ESMO, NICE and SIGN.

ABSTRACT:

Background

This is an appraisal of the impact of cited research evidence underpinning the development of cancer clinical practice guidelines (CPGs) by the professional bodies of the European Society for Medical Oncology (ESMO), the National Institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN).

Methods

A total of 101 CPGs were identified from ESMO, NICE and SIGN websites across 13 cancer sites. Their 9486 cited references were downloaded from the Web of Science Clarivate Group database, analysed on Excel (2016) using Visual Basic Application macros and imported onto SPSS (V.24.0) for statistical tests.

Results

ESMO CPGs mostly cited research from Western Europe, while the NICE and SIGN ones from the UK, Canada, Aust

SUBMITTER: Pallari E 

PROVIDER: S-EPMC5757472 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature